New HIV pill for kids pulled before start

NCT ID NCT06139796

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to test a new solid tablet combining two HIV drugs (darunavir and ritonavir) for children aged 3 and older weighing 10-25 kg. The goal was to find the right dose and check safety and acceptability. However, the trial was withdrawn before any participants were enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Darunavir/Ritonavir (DRV/r) 120/20 mg fixed-dose combination tablet

What this could lead to

If successful, this could provide a more convenient, child-friendly tablet option for treating HIV in children.

What could go wrong

The trial was withdrawn before enrolling any participants, so no data will be collected. The formulation may still need further testing in future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor College of Medicine Children's Foundation

    Kampala, Uganda, 72052, Uganda

  • Centre Hospitalier National d'Enfants Albert Royer

    Dakar, Senegal, 25755, Senegal

  • Centre Mère et Enfant de la Fondation Chantal Biya

    Yaoundé, Cameroon, 1, Cameroon

  • Joint Clinical Research Centre (JCRC)

    Kampala, Uganda

  • University of Zimbabwe Clinical Research Centre (UZCRC)

    Harare, Zimbabwe, Zimbabwe